Myocardial infarction in severe haemophilia

1Angelini D, Konkle BA, Sood SL. Aging among persons with hemophilia: contemporary concerns. Semin Hematol 2016; 53(1): 35-9.AngeliniDKonkleBASoodSLAging among persons with hemophilia: contemporary concernsSemin Hematol201653135910.1053/j.seminhematol.2015.10.004Search in Google Scholar

2Biere-Rafi S, Baarslag MA, Peters M, Kruip MJ, et al. Cardiovascular risk assessment in haemophilia patients. Thromb Haemost 2011; 105(2): 274-8.Biere-RafiSBaarslagMAPetersMKruipMJet alCardiovascular risk assessment in haemophilia patientsThromb Haemost20111052274810.1160/TH10-07-0460Search in Google Scholar

3Kamphuisen PW, ten Cate H. Cardiovascular risk in patients with hemophilia. Blood 2014; 123(9): 1297-301.KamphuisenPWten CateHCardiovascular risk in patients with hemophiliaBlood20141239129730110.1182/blood-2013-11-453159Search in Google Scholar

4Sousos N, Gavriilaki E, Vakalopoulou S, Garipidou V. Understanding cardiovascular risk in hemophilia: A step towards prevention and management. Thromb Res 2016; 140: 14-21.SousosNGavriilakiEVakalopoulouSGaripidouVUnderstanding cardiovascular risk in hemophilia: A step towards prevention and managementThromb Res2016140142110.1016/j.thromres.2016.02.001Search in Google Scholar

5Dolan G. The challenge of an ageing haemophilic population. Haemophilia 2010; 16 Suppl 5: 11-16.DolanGThe challenge of an ageing haemophilic populationHaemophilia201016 Suppl5111610.1111/j.1365-2516.2010.02287.xSearch in Google Scholar

6Cerrato E, Calcagno A, D'Ascenzo F, et al. Cardiovascular disease in HIV patients: from bench to bedside and backwards. Open Heart 2015; 2(1): e000174.CerratoECalcagnoAD'AscenzoFet alCardiovascular disease in HIV patients: from bench to bedside and backwardsOpen Heart201521e00017410.1136/openhrt-2014-000174Search in Google Scholar

7Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2017; 39(2): 119-77. doi: 10.1093/eurheartj/ehx393.IbanezBJamesSAgewallSet al2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)Eur Heart J20173921197710.1093/eurheartj/ehx393Open DOISearch in Google Scholar

8Helft G. Dual antiplatelet therapy duration after drug-eluting stents: how long? J Thorac Dis 2016; 8(8): E844-6.HelftGDual antiplatelet therapy duration after drug-eluting stents: how long?J Thorac Dis201688E844610.21037/jtd.2016.07.45Search in Google Scholar

9Schutgens RE, Tuinenburg A, Roosendaal G, Guyomi SH, Mauser-Bunschoten EP. Treatment of ischaemic heart disease in haemophilia patients: an institutional guideline. Haemophilia 2009; 15(4): 952-8.SchutgensRETuinenburgARoosendaalGGuyomiSHMauser-BunschotenEPTreatment of ischaemic heart disease in haemophilia patients: an institutional guidelineHaemophilia2009154952810.1111/j.1365-2516.2009.02020.xSearch in Google Scholar

10Philipp C. The aging patient with hemophilia: complications, comorbidities, and management issues. Hematology Am Soc Hematol Educ Program 2010; 2010: 191-6.PhilippCThe aging patient with hemophilia: complications, comorbidities, and management issuesHematology Am Soc Hematol Educ Program20102010191610.1182/asheducation-2010.1.191Search in Google Scholar

11Pocoski J, Ma A, Kessler CM, Boklage S, Humphries TJ. Cardiovascular comorbidities are increased in U.S. patients with haemophilia A: a retrospective database analysis. Haemophilia 2014; 20(4): 472-8.PocoskiJMaAKesslerCMBoklageSHumphriesTJCardiovascular comorbidities are increased in U.S. patients with haemophilia A: a retrospective database analysisHaemophilia2014204472810.1111/hae.12339Search in Google Scholar